Skip to main content

Carteolol ophthalmic Side Effects

Medically reviewed by Drugs.com. Last updated on Apr 16, 2023.

Applies to carteolol ophthalmic: ophthalmic solution.

Serious side effects

Along with its needed effects, carteolol ophthalmic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking carteolol ophthalmic:

Less common

Incidence not determined

Other side effects

Some side effects of carteolol ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not determined

For Healthcare Professionals

Applies to carteolol ophthalmic: ophthalmic solution.

General

The most commonly reported side effects were transient eye irritation, burning, tearing, conjunctival hyperemia, and edema.[Ref]

Ocular

Very common (10% or more): Transient eye irritation (25%), burning (25%), tearing (25%), conjunctival hyperemia (25%), edema (25%)

Frequency not reported: Blurred/cloudy vision, photophobia, decreased night vision, ptosis, ocular signs (including blepharoconjunctivitis, abnormal corneal staining, corneal sensitivity), keratitis, blepharoptosis, visual disturbances including refractive changes (due to withdrawal of miotic therapy in some cases), diplopia, sensation of foreign body, conjunctivitis, choroidal detachment following filtration surgery, dry eyes, corneal erosion[Ref]

Cardiovascular

Frequency not reported: Bradycardia, palpitations, arrhythmia, syncope, heart block, cerebral vascular accident, cerebral ischemia, congestive heart failure, chest pain, atrioventricular block, cardiac arrest, cardiac failure, hypotension, Raynaud's phenomenon, cold hands and feet[Ref]

Hypersensitivity

Frequency not reported: Angioedema, urticaria, localized and generalized rash, pruritus, anaphylactic reaction[Ref]

Dermatologic

Frequency not reported: Alopecia, psoriasiform rash or exacerbation of psoriasis[Ref]

Respiratory

Frequency not reported: Dyspnea, sinusitis, bronchospasm (predominantly in patients with pre-existing bronchospastic disease), respiratory failure, cough[Ref]

Nervous system

Frequency not reported: Headache, dizziness, taste perversion, memory loss, syncope, increases in signs and symptoms of myasthenia gravis, paresthesia, dysgeusia[Ref]

Psychiatric

Frequency not reported: Insomnia, depression, nightmares[Ref]

Gastrointestinal

Frequency not reported: Nausea, diarrhea, dry mouth, abdominal pain, vomiting, dyspepsia[Ref]

Genitourinary

Frequency not reported: Sexual dysfunction, decreased libido[Ref]

Metabolic

Frequency not reported: Hypoglycemia, masked symptoms of hypoglycemia in insulin-dependent diabetics[Ref]

Musculoskeletal

Frequency not reported: Myalgia[Ref]

Other

Frequency not reported: Asthenia, malaise, discomfort, edema, fatigue[Ref]

References

1. Product Information. Ocupress (carteolol ophthalmic). Ciba Vision Ophthalmics. 2001;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.